6,888
Views
43
CrossRef citations to date
0
Altmetric
Drug Approval Reports

Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials

ORCID Icon &
Pages 1-12 | Received 17 Jun 2020, Accepted 08 Aug 2020, Published online: 17 Sep 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.